Sialylation-related gene signature predict prognosis and immunotherapy efficacy in low- and high-grade glioma: a PCA-based stratification study
Open Access
- 9 December 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 15, 1676103
Abstract
Background: Sialylation is a crucial glycosylation modification of eukaryotic cell surface proteins. Tumor cell growth, immune evasion, and drug resistance are driven by excessive sialylation. However, the expression levels of genes associated with sialylation, prognostic value, and impact on the response to immunotherapy in brain tumors remain unclear. This study hypothesized that sialylation-related genes could serve as grouping genes to identify 20 significant genes for predicting the survival outcomes of patients with brain tumors and their responsiveness to immune checkpoint inhibitors. Methods: Using 83 genes related to sialylation, we classified the cohort into two distinct groups with marked differences in survival outcomes and immune cell infiltration. After identifying the differential genes, we subsequently performed unsupervised clustering, yielding two groups with high concordance. Principal component analysis (PCA) was used for dimensionality reduction in the two groups, with the PC1 and PC2 components defined as the PCA score. Results: A positive correlation was observed between the PCA score and immune cell infiltration, immune checkpoint expression, as well as chemokine expression, suggesting enhanced immunotherapy efficacy. We also validated the expression levels of KCNIP3 in patient tissues and found that this gene was overexpressed in U87 and LN229 cells, with low endogenous expression. These results demonstrate that KCNIP3 inhibits tumor cell proliferation, migration, and invasion. Moreover, intracranial xenograft results in mice were consistent with the in vitro findings. Conclusion: We developed a robust model to predict patient prognosis in low-grade gliomas and glioblastomas, emphasizing the prognostic significance of differentially expressed genes associated with sialylation.Keywords
This publication has 43 references indexed in Scilit:
- Enhancing cancer immunotherapy: Nanotechnology-mediated immunotherapy overcoming immunosuppressionActa Pharmaceutica Sinica B, 2024
- Sialic acid blockade inhibits the metastatic spread of prostate cancer to boneEBioMedicine, 2024
- The side effect registry immuno-oncology (SERIO) – A tool for systematic analysis of immunotherapy-induced side effectsEuropean Journal of Cancer, 2023
- CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastomaMolecular Therapy, 2022
- KCNIP3 silence promotes proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma through activating Wnt/β-catenin pathwayTissue and Cell, 2022
- clusterProfiler 4.0: A universal enrichment tool for interpreting omics dataThe Innovation, 2021
- Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014JAMA Oncology, 2018
- Protein Sialylation Regulates a Gene Expression Signature that Promotes Breast Cancer Cell PathogenicityACS Chemical Biology, 2016
- Calmodulin and STIM proteins: Two major calcium sensors in the cytoplasm and endoplasmic reticulumBiochemical and Biophysical Research Communications, 2015
- Posttranslational modifications of the Ia-associated invariant protein p41 after gene transferBiochemistry, 1988